Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2025 | 7 | $0.03 | $0.08 | $0.05 |
Q2 2025 | 3 | $0.06 | $0.07 | $0.06 |
Q3 2025 | 6 | $0.07 | $0.08 | $0.08 |
Q4 2025 | 5 | $0.06 | $0.08 | $0.07 |
Q1 2026 | 4 | $0.06 | $0.07 | $0.06 |
Q2 2026 | 3 | $0.08 | $0.10 | $0.09 |
Q3 2026 | 2 | $0.11 | $0.12 | $0.12 |
Q4 2026 | 2 | $0.08 | $0.10 | $0.09 |
Privia Health Group, Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $0.03 earnings per share for the quarter, missing analysts' consensus estimates of $0.05 by $0.02. The company had revenue of 437.92 M for the quarter and had revenue of 1.66 B for the year. Privia Health Group, Inc. has generated $0 earnings per share over the last year ($0.19 diluted earnings per share) and currently has a price-to-earnings ratio of 195.95. Privia Health Group, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 25th, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/07/2024 | Q3 2024 | $0.05 | $0.03 | -0.02 | $414.23 M | $437.92 M |
08/08/2024 | Q2 2024 | $0.05 | $0.03 | -0.02 | $411.50 M | $422.33 M |
05/09/2024 | Q1 2024 | $0.05 | $0.03 | -0.02 | $415.24 M | |
02/27/2024 | Q4 2023 | $0.04 | $0.02 | -0.02 | $440.83 M | |
11/03/2023 | Q3 2023 | $0.05 | $0.05 | -0 | $428.21 M | $417.28 M |
08/03/2023 | Q2 2023 | $0.06 | $0.06 | 0 | $409.17 M | $413.35 M |
05/04/2023 | Q1 2023 | $0.02 | $0.06 | 0.05 | $386.28 M | |
03/01/2023 | Q4 2022 | $0.16 | $364.42 M | |||
11/10/2022 | Q3 2022 | $0.00 | $0.00 | -0 | $318.22 M | $342.90 M |
08/11/2022 | Q2 2022 | -$0.01 | -$0.10 | -0.08 | $313.33 M | $335.54 M |
05/12/2022 | Q1 2022 | -$0.05 | -$0.17 | -0.12 | $313.80 M | |
03/25/2022 | Q4 2021 | -$0.11 | $275.33 M | |||
11/08/2021 | Q3 2021 | -$0.09 | -$0.09 | 0 | $215.15 M | $251.52 M |
08/09/2021 | Q2 2021 | -$1.66 | -$1.68 | -0.02 | $214.98 M | $225.76 M |
05/27/2021 | Q1 2021 | $0.05 | $213.61 M | |||
12/30/2020 | Q4 2020 | $0.04 | $213.70 M | |||
09/29/2020 | Q3 2020 | $0.16 | $207.17 M | |||
06/29/2020 | Q2 2020 | $0.05 | $183.26 M | |||
03/31/2020 | Q1 2020 | $0.05 | $212.94 M |
Privia Health Group, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 25th, 2025 based off last year's report dates.
The conference call for Privia Health Group, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Privia Health Group, Inc.'s latest earnings report can be read online.
Privia Health Group, Inc. (:PRVA) has a recorded annual revenue of $1.66 B.
Privia Health Group, Inc. (:PRVA) has a recorded net income of $1.66 B. Privia Health Group, Inc. has generated $0.2 earnings per share over the last four quarters.
Privia Health Group, Inc. (:PRVA) has a price-to-earnings ratio of 195.95 and price/earnings-to-growth ratio is -12.74.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED